Doctor profile · Federal record

Dr. Joseph Hawkins, M.D.

Specialist (CMS: Endocrinology) · Fresno, CA

  • NPI 1841296894
  • Accepts Medicare
  • MIPS 80.2 / 100 · 2023
  • 44 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
7230 N Millbrook Ave
Fresno, CA 937203340
(559) 431-6197
fax (559) 431-8827

Credentials & registration

NPPES · NUCC
NPI registered
June 2005 — 21 yrs on file
Profile last updated
October 21, 2008
Year of graduation
1982 — 44 yrs since
Specialty taxonomy
174400000X — NUCC code
State license (1)
California #00G510190

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1841296894. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
88,711
Distinct HCPCS
10
Medicare allowed
$1,446,726
HCPCS Description Services Patients Avg allowed
J3111 Injection, romosozumab-aqqg, 1 mg 61,950 83 $10
J0897 Injection, denosumab, 1 mg 21,360 306 $23
J3489 Injection, zoledronic acid, 1 mg 915 183 $9
77085 Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment 901 899 $55
96372 Injection of drug or substance under skin or into muscle 899 378 $15
77089 Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk 885 883 $43
99214 Established patient office or other outpatient visit, 30-39 minutes 635 574 $131
99215 Established patient office or other outpatient visit, 40-54 minutes 564 513 $182
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 160 160 $68
99205 New patient office or other outpatient visit, 60-74 minutes 60 60 $223

In context: peer comparison

Among 10 peers in Fresno Specialist, average services per provider: 802. This provider delivers 111× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$53,167
Transactions
181
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Lilly USA, LLC 87 $34,617.94
Novo Nordisk INC 24 $11,379.66
Amgen INC. 18 $6,107.31
Tandem Diabetes Care, INC. 5 $148.31
Radius Health, INC. 10 $141.97
Dexcom, INC. 7 $137.43
Boehringer Ingelheim Pharmaceuticals, INC. 5 $110.65
Antares Pharma, INC. 6 $99.99
Abbvie INC. 4 $97.93
Abbott Laboratories 5 $93.84
AstraZeneca Pharmaceuticals Lp 3 $64.92
Kyowa Kirin, INC. 3 $62.87
Xeris Pharmaceuticals, INC. 2 $31.34
Recordati_Rare_Diseases_INC. 1 $25.67
Ultragenyx Pharmaceutical INC. 1 $25.20

By nature of payment

Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$44,469
Travel and Lodging
$5,126
Food and Beverage
$3,572

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,306
Patients
378
Total drug cost
$270,747
Drug Type Claims Patients Total cost
Synthroid (Levothyroxine Sodium) Brand 485 149 $61,904
Levothyroxine Sodium Generic 234 75 $3,335
Rosuvastatin Calcium Generic 98 33 $2,153
Metformin Hcl ER (Metformin Hcl) Brand 94 33 $1,558
Estradiol Generic 51 11 $2,702
Atorvastatin Calcium Generic 41 15 $429
Liothyronine Sodium Generic 41 11 $3,361
Metformin Hcl Generic 41 14 $535
Ezetimibe Generic 37 0 $2,460
Alendronate Sodium Generic 35 14 $1,285

Frequently asked questions

Auto-generated from federal data
What is Dr. Joseph Hawkins's medical specialty?
Dr. Joseph Hawkins practices Specialist in Fresno, CA.
Where does Dr. Joseph Hawkins practice?
Dr. Joseph Hawkins practices at 7230 N Millbrook Ave, Fresno, CA 937203340. Office phone: 5594316197.
What is Dr. Joseph Hawkins's NPI?
Dr. Joseph Hawkins's National Provider Identifier (NPI) is 1841296894, issued by NPPES.
Does Dr. Joseph Hawkins accept Medicare assignment?
Yes. Dr. Joseph Hawkins accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Joseph Hawkins commonly perform?
Top Medicare-reported procedures in 2023: Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897); Injection, zoledronic acid, 1 mg (HCPCS J3489). Source: CMS Medicare Physician & Other Practitioners file.